These findings prompted the World Health Organization (WHO) to revise its guidelines in 2012, urging initiation of ART “as a matter of emergency (within two weeks of starting anti tuberculosis treatment)” in patients with CD4 counts <50 cells/μl and “as early as possible” in others. The gene discussed is CD4; the disease is tuberculosis.